Welcome To The Covalon Technologies Ltd HUB On AGORACOM
Advanced Medical Biosystems
Message: Technologies Grants Options
| March 4, 2009 |
| Covalon Technologies Grants Options |
| MISSISSAUGA, ONTARIO--(Marketwire - March 4, 2009) - Covalon Technologies Ltd. (TSX VENTURE:COV), has granted an aggregate of 50,000 options to purchase common shares at an exercise price of $0.56 per share to the Company's recently appointed director, David McFaul. The shares will vest quarterly over three years and expire five years after the grant date. About Covalon Covalon Technologies Ltd. is an advanced medical products company that has developed, patented and commercialized therapeutic biomaterials for wound care and surgical applications and coatings. Polymer chemistry and surface coating technology have been combined to create a range of time-release drug delivery platforms that are applied to medical devices to treat many critical conditions. A variety of applications for these technologies have been identified and specific products have been developed. The products offer features and benefits providing solutions to many of the problems caused by current devices and their material properties which are used by most medical device manufacturers and suppliers. The problems include infection, poor biocompatibility, and microbial attachment. |
Loading...
Loading...
New Message
Please
login
to post a reply